Global health insurance service company
H.R.3554/S.1909, the Pharmacy DIR Reform To Reduce Senior Drug Costs Act; H.R.4074, To expand the availability of supplemental benefits to certain Medicare Advantage enrollees; issues related to Pharmacy Direct and Indirect Remuneration (DIR); Proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap and direct negotiation of prescription drug prices. Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; Issues related to telehealth, including H.R. 1332/S. 368, the Telehealth Modernization Act and S. 1512, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021; Issues related to the H.R. 5376 Build Back Better Act, budget reconciliation legislation; July 24, 2020 Executive Orders that direct federal agencies to prioritize policies that would: (1) permit drug importation from Canada and other countries, and specifically authorizes the re-importation of insulin products; (2) ensure that prices charged to low-income uninsured patients for insulin and epinephrine at Federally Qualified Health Centers (FQHCs are federally subsidized clinics that commonly participate in the 340B drug pricing program) align with the costs at which the FQHC acquired the drugs; (3) ban drug rebates in Medicare that are not passed at the point of sale; and (4) advance a most favored nation (MFN) rule to lower Medicare drug payments to prices similar to what other countries pay.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
INVARIANT LLC
740 15th St NW, Floor 5, Washington, DC, 20005, US
BENJAMIN KLEIN KATHRYN WISE BENJAMIN KLEIN KATHRYN WISE